HopeStage
Back to all studies
Active Not RecruitingNCT05290025

Integrating smoking-cessation support into opioid treatment clinics

About this titleRead the official source — NCT05290025
Medication studyAges 18+NorwayAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
Bergen and 1 more locationSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 7, 2022
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
266
Sponsor
Haukeland University Hospital
Sponsor type
Hospital / academic medical center
Study type
Behavioral
Intervention type
Behavioural, Drug, Other
Locations
Norway
Age range
Over 18 Years
Official registry ID
NCT05290025
Official title
Show the full official title

Integration of Smoking Cessation Into Standard Treatment for People Receiving Opioid Agonist Therapy Who Are Smoking Tobacco: Protocol for a Randomised Controlled Trial

Recruitment & locations

Not recruiting

Bergen · Stavanger

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Haukeland University Hospital, a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including Nicotine patch, Nicotine gum and Nicotine lozenge.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Want to explore more studies?

Explore studies